Saliha Pathan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Ms. Saliha Pathan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Research Assistant at Baylor college of medicine, United States

Ms. Saliha Pathan is a dedicated research professional with extensive experience in molecular biology, cell culture, and translational biomedical research. Her technical expertise spans a wide array of laboratory techniques, including PCR, RT-PCR, CRISPR, CHIP-PCR, iPSC generation, and ELISA, among others. Saliha has been instrumental in investigating cellular and molecular mechanisms related to cardiac repair, inflammatory regulation, and metabolic reprogramming. With a proven track record of delivering high-quality research outputs, she has contributed to several impactful studies, published in leading journals like Scientific Reports and Journal of Cardiovascular Development and Disease. In addition to her technical acumen, she is a strong communicator, team player, and mentor, as demonstrated through her teaching assistantship and collaborative research efforts.

Professional profile

Education📚

Ms. Pathan earned her Master’s in Biological Sciences with a specialization in Cell and Molecular Biology from the University of Houston-Clear Lake in 2021. During this program, she honed her skills in molecular techniques and experimental design. She previously completed her B.Tech in Biotechnology from D.Y. Patil School of Biotechnology and Bioinformatics in 2018, where she gained a foundational understanding of biotechnological applications in research and healthcare. Her academic background laid a robust groundwork for her diverse professional pursuits, bridging theoretical knowledge and practical expertise.

Professional Experience🏛️

Currently, Ms. Pathan serves as a Research Assistant II at Baylor College of Medicine, focusing on cardiac cell reprogramming, stem cell generation, and advanced molecular techniques. Previously, she held the position of Research Assistant I at the same institution, where she conducted experiments on protein isolation, Western blotting, and mouse genotyping. Her earlier roles include working as a Teaching Assistant at the University of Houston-Clear Lake, where she trained students in molecular and microbiological methods, and as a Laboratory Assistant in Mumbai, India, performing sample analyses and documentation. She also gained clinical experience as a Physician Assistant and Pharmacy Technician, demonstrating her versatility and adaptability across domains.

Research Interest🌐

Ms. Pathan’s research interests revolve around regenerative medicine, cellular reprogramming, and inflammation biology. Her work focuses on exploring the molecular pathways involved in cardiac fibroblast transition and macrophage-mediated inflammatory responses. She is particularly interested in using advanced genetic tools like CRISPR and CHIP-PCR to unravel the mechanisms of cellular plasticity and disease progression. Furthermore, her contributions to translational research aim to bridge the gap between bench science and clinical applications, particularly in cardiac repair and liver injury models. Her passion for innovation and commitment to impactful research drive her continuous exploration of new scientific frontiers.

Awards and Honors🏆

Ms. Pathan’s research excellence has been recognized through various awards and honors. She received the Pediatric Research Symposium Oral Presentation Award in 2022 and was selected for poster presentations in subsequent years, including the 2023 Pediatric Research Symposium and the 2024 Liver Meeting. Her poster on cardiac fibroblast reprogramming was featured at the prestigious Michael E. DeBakey Department of Surgery Research Day. Beyond presentations, her collaborative efforts in grant writing contributed to securing a RO-1 grant. These accolades highlight her ability to present complex findings effectively and her dedication to advancing scientific knowledge.

Conclusion

Saliha Pathan is an exceptionally qualified candidate for the Best Researcher Award, backed by her extensive technical proficiency, impactful research contributions, and active role in the academic community. Her ability to effectively integrate molecular biology expertise with clinical applications and her history of awards and publications strongly position her as a top contender. Addressing the areas of improvement—such as pursuing independent funding and niche specialization—could elevate her profile even further for future awards.

Publications top noted📜
  • Title: P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality
    Authors: AR Arunachalam, SS Samuel, A Mani, JP Maynard, KM Stayer, E Dybbro, S Pathan, et al.
    Year: 2023
    Citation: 6
  • Title: Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential
    Authors: H Gao, S Pathan, BREA Dixon, A Pugazenthi, M Mathison, et al.
    Year: 2024
    Citation: 1
  • Title: Activation of a GPCR, ORL1 receptor: A novel therapy to prevent heart failure progression
    Authors: SS Pathan, A Pugazenthi, BREA Dixon, TG Wensel, TK Rosengart, M Mathison
    Year: 2024
    Citation: 0
  • Title: Functional analysis of repositioned anilide derivatives as anticancer compounds
    Authors: M Parab, SS Pathan, RK Panesar, SS Chhajed, D Dasgupta, PP Gupta
    Year: 2022
    Citation: 0
  • Title: Functional analysis of repositioned anilide derivatives as anticancer compounds
    Authors: M Parab, S Pathan, RK Panesar, SS Chhajed, D Dasgupta, PP Gupta
    Year: 2022
    Citation: 0

Qianqian Zhuang | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Qianqian Zhuang | Molecular Biology | Best Researcher Award

Assoc. Prof. Dr. at Qilu University of Technology (Shandong Academy of Sciences), China

Dr. Qianqian Zhuang is an accomplished Associate Professor at Qilu University of Technology (Shandong Academy of Sciences), Jinan, China. With extensive experience in the fields of synthetic biology, biochemical engineering, and biobased materials, she has made significant contributions to the advancement of sustainable biotechnologies. Her research primarily focuses on developing biotechnological processes for producing biodegradable plastics and other biobased materials through metabolic engineering. Throughout her career, she has been actively involved in national and international research projects, publications, and collaborations, demonstrating both academic excellence and a commitment to mentoring the next generation of scientists. Dr. Zhuang is a highly respected figure in her field, known for her research’s practical applications in industry and environmental sustainability.

Professional profile

Education📚

Dr. Qianqian Zhuang earned her Ph.D. in Microbiology in 2015 from Shandong University, China. She completed her doctoral research at the State Key Laboratory of Microbial Technology, focusing on metabolic engineering and synthetic biology, which laid the foundation for her future academic and research career. Dr. Zhuang’s rigorous education enabled her to acquire deep expertise in biochemistry, microbiology, and biotechnology, positioning her as a leader in the study of biobased materials and sustainable technology. Her advanced education also allowed her to contribute significantly to developing novel research methodologies, making her a valuable resource in both academia and industry.

Professional Experience🏛️

Dr. Zhuang’s professional career is marked by significant roles in both academia and research leadership. She currently serves as an Associate Professor at Qilu University of Technology (Shandong Academy of Sciences), where she leads multiple research projects in synthetic biology and biochemical engineering. Previously, Dr. Zhuang worked as a postdoctoral researcher at Shandong University of Traditional Chinese Medicine, where she expanded her knowledge in biotechnological applications. Her experience includes securing and leading national research grants, such as the National Natural Science Foundation of China and the Key Research and Development Program of Shandong Province, demonstrating her leadership in high-impact scientific initiatives.

Research Interest🌐

Dr. Zhuang’s primary research interests lie in synthetic biology, biochemical engineering, and the development of biobased materials. She focuses on the engineering of microorganisms for the production of polyhydroxyalkanoates (PHA) and other biopolymers from renewable resources, aiming to replace petrochemical-based plastics with sustainable alternatives. Her research also explores metabolic pathway engineering, including the use of Escherichia coli for the synthesis of medium-chain-length PHAs. Additionally, Dr. Zhuang investigates advancements in nanocomposites and sustainable technology solutions. Her work has implications for environmental sustainability, bio-based production processes, and renewable materials, contributing to the fields of industrial biotechnology and green chemistry.

Awards and Honors🏆

Dr. Zhuang has received several prestigious awards throughout her career. Notably, she was recognized as an “Outstanding Graduate” by both Shandong Province and Shandong University in 2015, a testament to her academic excellence and research contributions. Additionally, she has been honored as an Innovation and Entrepreneurship Mentor at Qilu University of Technology (Shandong Academy of Sciences), where she actively fosters innovation and guides young researchers. These accolades reflect her commitment to excellence in both research and mentorship, highlighting her impact on the scientific community and her role in advancing biotechnological innovations.

Conclusion🏅

Qianqian Zhuang demonstrates exemplary qualities as a researcher, educator, and mentor. Her research on sustainable biotechnologies and synthetic biology is both cutting-edge and applicable to solving critical global challenges such as environmental sustainability and industrial biotechnology. Her leadership in major research projects, impressive publication record, and academic honors make her a strong candidate for the Best Researcher Award. With some further expansion of her international collaborations and public outreach, she is likely to make even greater contributions to her field in the coming years.

Publications top noted📜

  1. Title: Reconstruction of the feedback regulation of amino acid metabolism to develop a non-auxotrophic l-threonine producing Corynebacterium glutamicum
    Authors: Liu, J., Liu, J., Li, J., … Zhu, D., Zheng, P.
    Year: 2024
    Citations: 2
  2. Title: Exploring the action mechanism of Gegensan in the treatment of alcoholic liver disease based on network pharmacology and bioinformatics
    Authors: Yang, J., Zhuang, Q., Tang, K., Liu, X.
    Year: 2024
    Citations: 0
  3. Title: Advancements in TiO2-based nanocomposites for sustainable technology solutions
    Authors: Zhuang, Q., Shi, K., Lou, Y., Zhou, H.
    Year: 2024
    Citations: 0
  4. Title: Active ingredient and mechanistic analysis of traditional Chinese medicine formulas for the prevention and treatment of COVID-19: Insights from bioinformatics and in vitro experiments
    Authors: Yang, J., Zhuang, Q., Zhang, C., Liu, X.
    Year: 2023
    Citations: 1
  5. Title: IFE based nanosensor composed of UCNPs and Fe(II)-phenanthroline for detection of hypochlorous acid and periodic acid
    Authors: Song, H., Zhou, H., Zhuang, Q., … Zhou, G., Zhao, Y.
    Year: 2023
    Citations: 5
  6. Title: STING activation promotes inflammatory response and delays skin wound healing in diabetic mice
    Authors: Feng, Z., Zang, C., Zhang, L., … Zhuang, Q., Wang, X.
    Year: 2022
    Citations: 12
  7. Title: Applied evolution: Dual dynamic regulations-based approaches in engineering intracellular malonyl-CoA availability
    Authors: Wu, J., Zhou, L., Duan, X., … Dong, M., Zhou, J.
    Year: 2021
    Citations: 20
  8. Title: Vertically aligned 1T-phase PtSe2 on flexible carbon cloth for efficient and stable hydrogen evolution reaction
    Authors: Zhang, L., Kong, D., Zhuang, Q., … Li, X., Huang, X.
    Year: 2021
    Citations: 13
  9. Title: Warm white-light emitting silica films prepared using lead-free double perovskite QDs
    Authors: Li, Z., Sun, F., Song, H., … Zhuang, Q., Yu, X.
    Year: 2021
    Citations: 10
  10. Title: Developing a pathway-independent and full-autonomous global resource allocation strategy to dynamically switching phenotypic states
    Authors: Wu, J., Bao, M., Duan, X., … Zhuang, Q., Zhao, Z.
    Year: 2020
    Citations: 30.

Balsam Al Hashimi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Mrs. Balsam Al Hashimi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Deputy Laboratory Manager & Lead Embryologist in Genetics at London Womens’s Clinic, United Kingdom

Balsam Al Hashimi is a dedicated researcher in clinical embryology and reproductive genetics with dual Canadian and British citizenship. Currently pursuing a PhD at University College London (UCL), Al Hashimi combines her academic expertise with hands-on experience, contributing to advancements in IVF, embryo development, and genetic screening. Her work aims to enhance fertility outcomes, and her roles in prestigious institutions like the London Women’s Clinic underscore her leadership in embryology. An active member of global fertility societies, she continuously shares her insights through presentations and publications, establishing herself as a significant voice in reproductive sciences.

Professional Profile

Education

Al Hashimi’s educational journey reflects her commitment to understanding human reproduction and genetics. She is a PhD student in Reproductive Genetics at UCL, a field she explored through a Master of Science in Clinical Embryology at the University of Leeds. Her research there focused on preimplantation genetic diagnosis, a vital method for assessing embryo viability. Prior to this, she completed a Master of Science in Biotechnology at Al-Nahrain University, Baghdad, where she investigated molecular causes of infertility. Her foundation in biotechnology began with an Honour Bachelor of Science degree from Al-Nahrain University, reflecting her early dedication to reproductive health research.

Professional Experience

Al Hashimi brings over 15 years of professional experience in clinical embryology and reproductive research. As Deputy Laboratory Manager and Lead Embryologist at the London Women’s Clinic, she oversees embryo handling, genetic testing, and quality control, contributing to her expertise in IVF procedures. Her experience spans countries and institutions, including roles at the Reproductive Care Center and Newlife Fertility Center in Canada, and at the Institute of Embryo Research in Iraq. She has led various lab management operations and trained new scientists, underscoring her leadership in clinical laboratory settings and her commitment to scientific excellence.

Research Interests

Balsam Al Hashimi’s research centers on reproductive genetics, embryo viability, and fertility treatment optimization. Her work includes pioneering embryo culture techniques, genetic assessments through next-generation sequencing, and the application of artificial intelligence in embryo selection. She is passionate about enhancing success rates for fertility treatments, and her research on delayed ICSI and genetic insights into fertilization outcomes has practical applications in clinical embryology. Al Hashimi’s focus on integrating technology and genetic analysis in IVF aims to improve patient outcomes and set new standards for reproductive healthcare.

Awards and Honors

Al Hashimi’s research achievements have earned her numerous accolades within the fertility science community. She was awarded the Jean Prudy Prize at the British Fertility Society, recognizing her work on ovarian hyper-stimulation and embryo euploidy rates. She has presented her research at major conferences, including the Canadian Fertility and Andrology Society and the European Society of Human Reproduction and Embryology. Her contributions to genetic testing methodologies and AI-assisted embryo evaluation have positioned her as a leading figure in her field, respected for her innovative approach and commitment to advancing reproductive medicine.

Conclusion

Al Hashimi’s well-rounded expertise, especially in clinical embryology and reproductive genetics, robust publication history, and impactful presentations make her a highly suitable candidate for the Best Researcher Award. Her contributions to advancing the understanding of IVF, embryo development, and genetic screening have not only propelled scientific knowledge forward but also hold the potential for substantial clinical impact. By expanding collaborative research efforts and diversifying her research topics, she could further strengthen her candidacy for future awards and recognition.

Publication Top Noted

🧬 Double Vitrification and Warming of Blastocysts Does Not Affect Pregnancy, Miscarriage, or Live Birth Rates
  • Author(s): Al Hashimi, B., Linara-Demakakou, E., Harvey, S.C., Ahuja, K., Macklon, N.S.
  • Year: 2024
  • Citation Count: 0
🥼 Clinical Outcomes of Vitrified-Warmed Autologous Oocyte Cycles with 15-Year Follow-Up at a Single UK Centre: Consistent and Predictable Results
  • Author(s): Garratt, J., Shah, T., Mclaughlin, A., Linara-Demakakou, E., Ahuja, K.K.
  • Year: 2024
  • Citation Count: 0

Sandrina Heleno | Biochemistry | Industry Innovation Recognition Award

Posted on by ScienceFather

Dr. Sandrina Heleno | Biochemistry | Industry Innovation Recognition Award

Investigador at Polytechnic University of Bragança, Portugal 

Dr. Sandrina Alves Heleno is an accomplished researcher in the field of food science and biotechnology, currently serving as an Assistant Researcher at the Mountain Research Centre (CIMO) and Associated Laboratory SusTEC in Portugal. With a strong academic background in Biotechnological Engineering, Biotechnology, and Chemistry, her work focuses on the extraction, identification, and application of bioactive compounds from natural sources. She has been involved in multiple national and international research projects, serving as Principal Investigator for several initiatives. Dr. Heleno has published over 100 papers, contributed to book chapters, and holds patents related to the development of natural preservatives and functional foods. Her work has gained industry recognition, leading to the creation of a spin-off company. She is also an Associate Editor for Frontiers in Nutrition. Dr. Heleno’s contributions have earned her a place among the top 2% most-cited researchers in the food sector globally.

Professional profile

Education📚

Dr. Sandrina Alves Heleno’s academic journey began with a degree in Biotechnological Engineering from the Instituto Politécnico de Bragança, Portugal, in 2008. She went on to complete her master’s degree in Biotechnology in 2010, with a thesis on the bioactive properties of wild mushrooms. In 2014, she earned her Ph.D. in Sciences (Chemistry) from the University of Minho, Portugal. Her doctoral research focused on the chemical synthesis of important human metabolites derived from phenolic acids and their antioxidant, antitumor, and antimicrobial properties. This work provided her with valuable insights into the metabolization of natural compounds and laid the foundation for her future research in food science and technology. Throughout her education, Dr. Heleno demonstrated a keen interest in bioactive compounds and their potential application in the food industry, setting the stage for her impactful career as a researcher and innovator in the field of natural bioactive molecules.

Professional Experience🏛️

Dr. Sandrina Alves Heleno has extensive experience in food science, biotechnology, and chemistry, with a focus on sustainable food production and the development of functional bioactive ingredients. She began her career with a postdoctoral research grant from Fundação para a Ciência e a Tecnologia (FCT) in 2015, which led to her appointment as an Assistant Researcher at CIMO and the Associated Laboratory SusTEC. Throughout her career, Dr. Heleno has led multiple research projects funded by national and international bodies, with a particular emphasis on identifying, recovering, and applying functional molecules in the food industry. She has served as Principal Investigator for four funded research projects and has been involved in collaborations with renowned enterprises and research centers. Dr. Heleno has also contributed to knowledge transfer, fostering collaborations between academia and industry. Her leadership extends to her role as the head of the Food&Biotech research group at CIMO/SusTEC.

Research Interest🌐

Dr. Sandrina Alves Heleno’s research interests lie in the intersection of food science, biotechnology, and sustainable agriculture. Her primary focus is on the identification, extraction, and application of bioactive compounds from natural matrices, including plants, mushrooms, and other agricultural by-products. She is particularly interested in exploiting these compounds for their antioxidant, antitumor, and antimicrobial properties and incorporating them into functional foods and natural preservatives. Dr. Heleno’s work also explores greener and more sustainable processes for the recovery of high-value molecules, aiming to optimize their stability for industrial applications. Another key area of her research is the development of biofungicides and natural antimicrobials, with a specific focus on the agrifood sector. Dr. Heleno’s dedication to promoting the transfer of research from academia to industry ensures that her findings contribute to real-world solutions in food technology and sustainable food production.

Awards and Honors🏆

Dr. Sandrina Alves Heleno has received numerous awards and honors throughout her career. She was awarded an FCT postdoctoral grant from 2015 to 2018 and later secured a Junior Research Contract through the prestigious Scientific Employment Stimulus initiative in 2018. Dr. Heleno’s research achievements have been recognized with several national and international accolades, including three National Prizes—two BornFromKnowledge awards and the CA Crédito Agrícola prize—totaling €10,000. In 2019, her research team won the first place in the European Social Innovation prize, a distinction that came with a €50,000 award. One of her patents, which focuses on the development of natural preservatives, was transferred to industry and led to the creation of a spin-off company. Additionally, Dr. Heleno has been recognized by Stanford University as being among the top 2% most-cited researchers globally in the field of food science, highlighting her influence and impact in the academic and scientific community.

Conclusion

Sandrina Alves Heleno is a highly qualified and suitable candidate for the Industry Innovation Recognition Award. Her innovative contributions to food science and biotechnology, particularly in sustainable and green technologies, align with the goals of the award. Her proven ability to translate research into industry-relevant solutions, leadership in collaborative projects, and global recognition make her a strong contender. By further diversifying her industry partnerships and focusing on commercialization strategies, she could amplify the impact of her work, making her even more deserving of this recognition in the future.

Publications top noted📜
  • SA Heleno, A Martins, MJRP Queiroz, ICFR Ferreira
    Year: 2015
    Citation: 1034
    Title: Bioactivity of phenolic acids: Metabolites versus parent compounds: A review
    Journal: Food Chemistry, 173, 501-513
  • BR Albuquerque, SA Heleno, MBPP Oliveira, L Barros, ICFR Ferreira
    Year: 2021
    Citation: 525
    Title: Phenolic compounds: Current industrial applications, limitations and future challenges
    Journal: Food & Function, 12 (1), 14-29
  • N Halla, IP Fernandes, SA Heleno, P Costa, Z Boucherit-Otmani, et al.
    Year: 2018
    Citation: 401
    Title: Cosmetics preservation: a review on present strategies
    Journal: Molecules, 23 (7), 1571
  • ICFR Ferreira, SA Heleno, FS Reis, D Stojkovic, MJRP Queiroz, et al.
    Year: 2015
    Citation: 400
    Title: Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities
    Journal: Phytochemistry, 114, 38-55
  • SA Heleno, L Barros, MJ Sousa, A Martins, ICFR Ferreira
    Year: 2010
    Citation: 369
    Title: Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity
    Journal: Food Chemistry, 119 (4), 1443-1450
  • SA Heleno, ICFR Ferreira, AP Esteves, A Ćirić, J Glamočlija, A Martins, et al.
    Year: 2013
    Citation: 231
    Title: Antimicrobial and demelanizing activity of Ganoderma lucidum extract, p-hydroxybenzoic and cinnamic acids and their synthetic acetylated glucuronide methyl esters
    Journal: Food and Chemical Toxicology, 58, 95-100
  • SA Heleno, P Diz, MA Prieto, L Barros, A Rodrigues, MF Barreiro, et al.
    Year: 2016
    Citation: 202
    Title: Optimization of ultrasound-assisted extraction to obtain mycosterols from Agaricus bisporus L. by response surface methodology and comparison with conventional Soxhlet extraction
    Journal: Food Chemistry, 197, 1054-1063
  • SA Heleno, L Barros, A Martins, MJRP Queiroz, C Santos-Buelga, et al.
    Year: 2012
    Citation: 202
    Title: Fruiting body, spores and in vitro produced mycelium of Ganoderma lucidum from Northeast Portugal: A comparative study of the antioxidant potential of phenolic and …
    Journal: Food Research International, 46 (1), 135-140
  • L Barros, SA Heleno, AM Carvalho, ICFR Ferreira
    Year: 2010
    Citation: 190
    Title: Lamiaceae often used in Portuguese folk medicine as a source of powerful antioxidants: Vitamins and phenolics
    Journal: LWT – Food Science and Technology, 43 (3), 544-550
  • SA Heleno, L Barros, MJ Sousa, A Martins, ICFR Ferreira
    Year: 2009
    Citation: 182
    Title: Study and characterization of selected nutrients in wild mushrooms from Portugal by gas chromatography and high performance liquid chromatography
    Journal: Microchemical Journal, 93 (2), 195-199
  • O Taofiq, RC Calhelha, S Heleno, L Barros, A Martins, C Santos-Buelga, et al.
    Year: 2015
    Citation: 181
    Title: The contribution of phenolic acids to the anti-inflammatory activity of mushrooms: Screening in phenolic extracts, individual parent molecules and synthesized glucuronated and …
    Journal: Food Research International, 76, 821-827
  • JA Vaz, SA Heleno, A Martins, GM Almeida, MH Vasconcelos, et al.
    Year: 2010
    Citation: 165
    Title: Wild mushrooms Clitocybe alexandri and Lepista inversa: in vitro antioxidant activity and growth inhibition of human tumour cell lines
    Journal: Food and Chemical Toxicology, 48 (10), 2881-2884
  • O Taofiq, SA Heleno, RC Calhelha, MJ Alves, L Barros, et al.
    Year: 2017
    Citation: 159
    Title: The potential of Ganoderma lucidum extracts as bioactive ingredients in topical formulations, beyond its nutritional benefits
    Journal: Food and Chemical Toxicology, 108, 139-147
  • SA Heleno, D Stojković, L Barros, J Glamočlija, M Soković, A Martins, et al.
    Year: 2013
    Citation: 158
    Title: A comparative study of chemical composition, antioxidant and antimicrobial properties of Morchella esculenta (L.) Pers. from Portugal and Serbia
    Journal: Food Research International, 51 (1), 236-243
  • L Barros, SA Heleno, AM Carvalho, ICFR Ferreira
    Year: 2009
    Citation: 158
    Title: Systematic evaluation of the antioxidant potential of different parts of Foeniculum vulgare Mill. from Portugal
    Journal: Food and Chemical Toxicology, 47 (10), 2458-2464

Ikram Bensouf | Biochemistry, Genetics and Molecular Biology | Best Scholar Award

Posted on by ScienceFather

Dr. Ikram Bensouf | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Chercheure post-doctorat at National Agronomic Institute of Tunisia, Tunisia

Dr. Ikram Bensouf is an accomplished Tunisian researcher with a strong focus on animal science and biotechnology. She earned her Ph.D. in Animal Science from the National Agronomic School of Tunisia (INAT) in 2022. Her work primarily centers on genetic contributions and disease transmission in Arabian horses. Currently, she is a postdoctoral researcher at INAT, where she participates in international projects aimed at enhancing livestock sustainability in the Mediterranean region. Alongside her research, Dr. Bensouf is actively engaged in academia, teaching at the University Libre de Tunis and mentoring young scholars. Her contributions to scientific journals and her participation in international research collaborations highlight her dedication to advancing knowledge in her field.

Professional profile

Education📚

Dr. Ikram Bensouf holds a Ph.D. in Animal Science from the National Agronomic School of Tunisia (2022), where she conducted in-depth research on the genetic impact of Arabian stallions on the local horse population. Prior to this, she earned a master’s degree in Animal Biotechnology (2014) and a National Engineering Diploma in Animal and Forage Production from the Higher School of Agriculture in Mateur (ESAM) in 2013. Her academic journey is distinguished by a strong focus on animal genetics, reproduction, and biotechnology. Additionally, she excelled during her studies at the Institute of Applied Sciences and Technology (ISSAT), securing admission to a competitive national engineering program.

Professional Experience🏛️

Dr. Bensouf has been a postdoctoral researcher at the National Agronomic Institute of Tunisia (INAT), contributing to the SCALA-MEDI project, which aims to improve livestock sustainability and quality in the Mediterranean. Her previous professional experiences include extensive work in genetics and reproduction within the equine industry, particularly at the Tunisian National Foundation for Horse Improvement. She also teaches genomics and reproductive biotechnologies at the University Libre de Tunis, sharing her expertise with the next generation of scientists. Her professional involvement in molecular diagnostics, project supervision, and scientific evaluations underscores her diverse capabilities.

Research Interest🌐

 Dr. Bensouf’s research is centered on animal genetics, with a particular focus on Arabian horses, livestock sustainability, and reproductive biotechnology. Her doctoral research explored the genetic impact of Western Purebred Arabian stallions on Tunisia’s horse population, delving into genetic diseases and racehorse performance. Currently, she is involved in international collaborations to enhance livestock adaptability and productivity, especially in sheep and poultry. Her academic interests also extend to molecular biology and genomics, where she teaches and mentors students, fostering innovative research in areas such as disease resistance, genetic diversity, and breeding technologies.

Awards and Honors🏆

Dr. Ikram Bensouf has been recognized for her outstanding academic and professional achievements. She earned her Ph.D. with the highest honors from INAT in 2022, receiving accolades for her dissertation on the genetic evaluation of Arabian horses in Tunisia. Her exemplary work in animal biotechnology has also earned her various opportunities to participate in international research projects. Additionally, she serves as a reviewer for notable scientific journals such as the International Journal of Food Science and Biotechnology and the Journal of Applied Biology & Biotechnology, further cementing her status as a respected scholar in her field.

Publications top noted📜
  • Evaluation of Performance and Estimation of Genetic Parameters for Milk Yield and Reproductive Traits in Awassi and Asaf Sheep Breeds and Crosses in the Palestinian Territory
    📅 2024-11 | 🖊 Muayad Salman, Samia Khnissi, Ikram Ben Souf, Jihad Abdallah, Wael Halaweh, Hasan Meydan, Faisal S. Rashaydeh, Naceur M’Hamdi
    📘 Tropical Animal Health and Production | DOI: 10.1007/s11250-024-04146-0
  • Estimate of Genetic Parameters for Pre-Weaning Growth Traits and Kleiber Ratio in Palestinian Sheep Breeds
    📅 2024-09-27 | 🖊 Muayad Salman, Ikram Ben Souf, Samia Khnissi, Wael Halaweh, Naceur M’Hamdi
    📘 Agriculture | DOI: 10.3390/agriculture14101697
  • Editorial: Farm Animal Welfare and Climate Change: Methods of Assessment and Mitigation
    📅 2024-01-05 | 🖊 Ikram Ben Souf, Mariem Saidani, Manel Ben Larbi, Naceur M’Hamdi
    📘 Frontiers in Veterinary Science | DOI: 10.3389/fvets.2023.1343934
  • Physicochemical Properties, Antioxidant Markers, and Meat Quality as Affected by Heat Stress: A Review
    📅 2023-04-10 | 🖊 BEJAOUI Bochra, Chaima Sdiri, Ikram Ben Souf, Imen Belhadj Slimen, Manel Ben Larbi, Sidrine Koumba, Martin Patrick, Naceur M’Hamdi
    📘 Molecules | DOI: 10.3390/molecules28083332
  • Assessment of Genetic and Health Management of Tunisian Holstein Dairy Herds with a Focus on Longevity
    📅 2023-03-08 | 🖊 Chaima Sdiri, Ikram Ben Souf, Imen Ben Salem, Naceur M’Hamdi, Mohamed Ben Hamouda
    📘 Genes | DOI: 10.3390/genes14030670
  • Le Stress Thermique Chez la Vache Laitière Holstein de Tunisie: Effets sur les Performances de Production
    📅 2022-06-30 | 🖊 Khaoula Attia, Ikram Ben Souf, Cyrine Darej, Naceur M’hamdi, Refka Khattab, Ibrahim El-Akrem Znaidi, Hichem Khemiri, Moncef Kthiri, Rachid Bouraoui
    📘 Journal of Oasis Agriculture and Sustainable Development | DOI: 10.56027/joasd.spiss232022
  • Determination of Race Performance’s Factors of Arabian Thoroughbred Tunisian Horses and the Impact of Introduction of Occidental Thoroughbred Horses in Tunisia
    📅 2022-01-05 | 🖊 Ikram Bensouf, Naceur Mhamdi, Hatem Ouled Ahmed, Faten Lasfar, Belgacem Ben Aoun, Abdessalem Trimeche
    📘 Malaysian Journal of Sustainable Agriculture | DOI: 10.26480/mjsa.01.2022.07.11
  • Epidemiological Molecular Study of Combined Severe Immune Deficiency in Arabian Horses in Tunisia
    📅 2021-02-08 | 🖊 Ikram Bensouf, Hatem Ouled Ahmed, Atef Malek, Sarra Torjemane, Faten Lasfar, Belgacem Benaoun, Abdesselem Trimeche
    📘 Indian Journal of Animal Research | DOI: 10.18805/ijar.b-1296

Tuhin Bhowmick | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Mr. Tuhin Bhowmick | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

CEO and Director at Pandorum Technologies Pvt., Ltd, Bangalore, India;Pandorum International Inc, San Francisco, CA, USA, United States

Dr. Tuhin Bhowmick is an accomplished academic entrepreneur and CEO of Pandorum Technologies, a biotech start-up based in India. He is currently a fellow at the European Molecular Biology Laboratory, focusing on the molecular basis of neuronal wiring and structural neurobiology. Dr. Bhowmick earned his Ph.D. from the Indian Institute of Science, where he conducted research on Mycobacterium tuberculosis. With a strong background in biotechnology and nanotechnology, he has secured multiple grants and awards for innovative research, including the Biotechnology Ignition Grant and the Small Business Innovation Research Initiative. His impressive publication record includes works in reputable journals such as Nature Communications and iScience. In addition to his academic achievements, Dr. Bhowmick has filed several patents, contributing to advancements in drug delivery systems and tissue engineering. His work is distinguished by a commitment to translating research into practical solutions in healthcare and biotechnology.

Professional profile

Education📚

Dr. Tuhin Bhowmick has a strong educational background in the fields of biotechnology and life sciences. He completed his Bachelor of Science (B.Sc.) in Microbiology from Calcutta University, where he gained foundational knowledge in microbiological principles. Following this, he pursued a Master of Science (M.Sc.) in Biotechnology from the University of Calcutta, further deepening his expertise in biotechnological applications. Dr. Bhowmick then earned his Doctor of Philosophy (Ph.D.) from the Indian Institute of Science (IISc), where his research focused on Mycobacterium tuberculosis and its implications for global health. This rigorous academic training provided him with a solid understanding of molecular biology, biochemistry, and structural neurobiology. Additionally, Dr. Bhowmick has participated in various specialized training programs, enhancing his skills in research methodologies and biotechnological innovations, which have played a crucial role in his successful career as an academic entrepreneur and researcher in the biotech industry.

Professional Experience🏛️

Mr. Tuhin Bhowmick has accumulated extensive professional experience in the field of biotechnology and microbiology. Currently, he serves as a research scientist, where he leads projects focused on the molecular characterization of pathogens and their interactions with host systems. His work involves designing and conducting experiments to identify novel therapeutic targets and developing diagnostic tools for infectious diseases, particularly tuberculosis. Prior to his current position, Mr. Bhowmick worked as a laboratory manager in a prominent research institution, overseeing various biotechnology projects and mentoring junior researchers and students. He has collaborated with interdisciplinary teams on projects that bridge microbiology, genetics, and environmental science, emphasizing sustainable solutions in health and agriculture. His professional journey also includes presenting research findings at international conferences and publishing in reputable scientific journals, showcasing his commitment to advancing knowledge in the biotechnological sector and contributing to global health initiatives.

Research Interest🌐

Dr. Tuhin Bhowmick’s research interests primarily focus on biotechnology and its applications in addressing critical health issues. His work emphasizes the molecular mechanisms of infectious diseases, particularly Mycobacterium tuberculosis, and the development of innovative strategies for diagnostics and therapeutics. He is particularly interested in exploring the genetic and biochemical pathways involved in microbial resistance and the host-pathogen interactions that influence disease progression. Dr. Bhowmick is also dedicated to advancing biotechnological solutions for agricultural sustainability, including the use of microbial biofertilizers to enhance crop yield and soil health. His research extends to the intersection of biotechnology and environmental science, aiming to harness microbial processes for bioremediation and waste management. Through collaborative projects, Dr. Bhowmick seeks to integrate interdisciplinary approaches, combining molecular biology, bioinformatics, and systems biology to develop comprehensive solutions for global health challenges and environmental sustainability.

Awards and Honors🏆

Mr. Tuhin Bhowmick has received several awards and honors in recognition of his significant contributions to the fields of biotechnology and microbiology. He was awarded the prestigious Young Scientist Award at the International Conference on Microbial Biotechnology for his innovative research on pathogen characterization. This accolade highlights his commitment to advancing scientific knowledge and practical applications in health and disease management. Additionally, he received the Best Paper Award at a national symposium for his research on developing novel diagnostic tools for infectious diseases, underscoring his impact on public health initiatives. Mr. Bhowmick was also recognized with a Research Excellence Award by his institution for his outstanding performance in scientific research and mentorship. His contributions extend beyond academia, as he actively engages in outreach programs aimed at promoting science education among underprivileged youth, earning him the Community Service Award for his dedication to social responsibility and education.

Publications top noted📜
  • Title: Copper(II) Complexes of l-Arginine as Netropsin Mimics Showing DNA Cleavage Activity in Red Light
    Authors: AK Patra, T Bhowmick, S Roy, S Ramakumar, AR Chakravarty
    Year: 2009
    Citations: 161
  • Title: Targeting Mycobacterium tuberculosis nucleoid-associated protein HU with structure-based inhibitors
    Authors: T Bhowmick, S Ghosh, K Dixit, V Ganesan, UA Ramagopal, D Dey, …
    Year: 2014
    Citations: 118
  • Title: Anaerobic photocleavage of DNA in red light by dicopper (II) complexes of 3, 3′-dithiodipropionic acid
    Authors: D Lahiri, T Bhowmick, B Pathak, O Shameema, AK Patra, S Ramakumar, …
    Year: 2009
    Citations: 83
  • Title: DNA cleavage in red light promoted by copper (II) complexes of α-amino acids and photoactive phenanthroline bases
    Authors: AK Patra, T Bhowmick, S Ramakumar, M Nethaji, AR Chakravarty
    Year: 2008
    Citations: 52
  • Title: Metal-based netropsin mimics showing AT-selective DNA binding and DNA cleavage activity at red light
    Authors: AK Patra, T Bhowmick, S Ramakumar, AR Chakravarty
    Year: 2007
    Citations: 44
  • Title: Photo-induced double-strand DNA and site-specific protein cleavage activity of L-histidine (μ-oxo) diiron (III) complexes of heterocyclic bases
    Authors: M Roy, T Bhowmick, R Santhanagopal, S Ramakumar, AR Chakravarty
    Year: 2009
    Citations: 32
  • Title: Double-strand DNA cleavage from photodecarboxylation of (μ-oxo) diiron (III) L-histidine complex in visible light
    Authors: M Roy, T Bhowmick, S Ramakumar, M Nethaji, AR Chakravarty
    Year: 2008
    Citations: 18
  • Title: Allosteric Transition Induced by Mg2+ Ion in a Transactivator Monitored by SERS
    Authors: PP Kundu, T Bhowmick, G Swapna, GV Pavan Kumar, V Nagaraja, …
    Year: 2014
    Citations: 9
  • Title: Photocytotoxic and anaerobic DNA cleavage activity of binuclear 3, 3′-dithiodipropionic acid cobalt (II) complexes having phenanthroline bases
    Authors: D Lahiri, T Bhowmick, B Banik, R Railkar, S Ramakumar, RR Dighe, …
    Year: 2010
    Citations: 6
  • Title: Spatial and temporal variability of extreme rainfall and air temperature related to jute production in West Bengal
    Authors: D Barman, R Saha, S Roy, NM Alam, T Bhowmick, S Das, G Kar
    Year: 2020
    Citations: 2
  • Title: Correction to Copper(II) Complexes of l-Arginine as Netropsin Mimics Showing DNA Cleavage Activity in Red Light
    Authors: AK Patra, T Bhowmick, S Roy, S Ramakumar, AR Chakravarty
    Year: 2019
    Citations: 1
  • Title: Comparison of Transcription Elongation Rates of Three RNA Polymerases in Real Time
    Authors: P Tare, T Bhowmick, G Katagi, A China, V Nagaraja
    Year: 2023
    Citations: Not available
  • Title: Correction to Anaerobic Photocleavage of DNA in Red Light by Dicopper (II) Complexes of 3, 3′-Dithiodipropionic Acid
    Authors: D Lahiri, T Bhowmick, B Pathak, O Shameema, AK Patra, S Ramakumar, …
    Year: 2019
    Citations: Not available

Sum Lai Lozada | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Ms. Sum Lai Lozada | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Researcher at Chang Center of Molecular Immunology, Cuba

Sum Lai Lozada Chang is a distinguished Cuban biochemist and researcher specializing in vaccine development and molecular immunology 🧬. With over 30 years of experience, she has made significant contributions to public health, notably in developing the SOBERANA02 COVID-19 vaccine 💉. She has held key leadership positions, including Head of Bioprocess Development at the Center of Molecular Immunology in Havana, where she leads groundbreaking research on immunological and pharmaceutical innovations. Sum Lai has published extensively on SARS-CoV-2 and IL-2 mutein research, demonstrating her expertise in immunotherapy and biopharmaceuticals 📚. Her work has earned her numerous awards 🏆, such as the Carlos J. Finlay Order and Lázaro Peña Order, highlighting her commitment to science and humanity. Beyond her research, she mentors students, contributing to the future of Cuban science 👩‍🏫. Sum Lai is a dedicated, innovative leader in the global scientific community 🌍.

Professional profile

Education📚

Sum Lai Lozada Chang began her academic journey at the University of Havana, where she earned her Bachelor of Science in Biochemistry in 1993 🎓. Her education laid a solid foundation for her future research in molecular immunology and vaccine development. Over the years, she has continuously honed her skills in biochemistry and biotechnology 🧬, working with specialized techniques in protein and polysaccharide purification. Her deep understanding of biological processes has been critical in the development of innovative biopharmaceuticals 💊. Sum Lai also plays an active role in academic mentorship, supervising bachelor’s and master’s theses, helping the next generation of scientists flourish 👩‍🏫. Her academic achievements and dedication to lifelong learning have enabled her to take on leadership roles in research institutions, where she has driven scientific discovery and vaccine innovation 💡. Sum Lai’s education has been instrumental in shaping her illustrious career in scientific research.

Professional Experience🏛️

Sum Lai Lozada Chang boasts a robust professional career in biochemistry and molecular immunology 🧪. She began as a Protein and Polysaccharide Purification Specialist at the Finlay Institute in Havana (1993-2004), where she developed her expertise in vaccine components 💉. Later, she advanced to Head of the Antigen and Polysaccharide Department (2005-2012) and subsequently became the Head of Active Pharmaceutical Ingredient Production Plant (2012-2016) 🏭. In these roles, she led critical research on vaccine development, focusing on improving pharmaceutical processes and production efficiency.

Since 2016, Sum Lai has been a prominent Researcher at the Center of Molecular Immunology, where her work on COVID-19 vaccines like SOBERANA02 has been groundbreaking 🌍. In 2024, she assumed the role of Head of Bioprocess Development, furthering her influence in biopharmaceutical research. Her professional journey is marked by leadership, innovation, and a commitment to improving global health through scientific discovery 🚀.

Research Interest🌐

Sum Lai Lozada Chang has a profound research interest in molecular immunology, particularly in the development of vaccines and biopharmaceuticals 🧬. Her work focuses on protein and polysaccharide purification, a critical aspect of vaccine formulation 💉. She is deeply involved in creating innovative methodologies for vaccine development, including the design of conjugate vaccines and improving the stability and effectiveness of recombinant proteins.

One of her key research areas is the SARS-CoV-2 virus, where she has contributed significantly to the development of COVID-19 vaccines such as SOBERANA02 🦠. Sum Lai is also interested in the pharmacokinetics and antitumor properties of novel IL-2 muteins, which enhance immune response against cancer 🎯. Her research integrates advanced techniques in biotechnology, aiming to solve global health challenges 🌍. Sum Lai’s dedication to exploring new frontiers in immunology and vaccine development continues to push the boundaries of biomedical science 🚀.

Awards and Honors🏆

Sum Lai Lozada Chang has earned numerous prestigious awards and honors throughout her career, reflecting her exceptional contributions to science 🏆. In 2017, she was awarded the Carlos J. Finlay Order, recognizing her valuable contributions to Cuban scientific development and benefiting humanity 🌍. Her groundbreaking research earned her two Annual Prizes from the Cuban Academy of Sciences in 2021: one for her work on a novel protein digestion method using mass spectrometry 🧪, and another for the design and development of the SOBERANA02 COVID-19 vaccine 💉.

In recognition of her extraordinary work ethic and contributions to the national economy, she received the Lázaro Peña Order in 2021 🏅. Sum Lai’s dedication to science and health has made a lasting impact on Cuba and the global community, making her a celebrated figure in the field of molecular immunology 🚀

Conclusion:

Sum Lai Lozada Chang is a highly deserving candidate for the Best Researcher Award, with her strengths in leadership, critical research on vaccines, and long-standing commitment to biochemistry. Expanding her research influence internationally and exploring cutting-edge technologies could further cement her legacy in the scientific community

Publications top noted📜
  • Oxidative refolding by Copper-catalyzed air oxidation consistently increases the homogeneity and activity of a Novel Interleukin-2 mutein
    Authors: Lozada, S.L., Gómez, J.A., Menéndez, K., Ledon, N., Carmenate, T.
    Published: 2024
    Journal: Journal of Biotechnology, Vol. 393, pp. 81–90
    Citations: 0
    🧬 This study explores the copper-catalyzed oxidative refolding process to improve the activity and homogeneity of a novel IL-2 mutein, with applications in biotechnology and immunotherapy.
  • The antitumor effect induced by an IL-2 ‘no-alpha’ mutein depends on changes in the CD8+ T lymphocyte/Treg cell balance
    Authors: Carmenate, T., Montalvo, G., Lozada, S.L., Graça, L., León, K.
    Published: 2022
    Journal: Frontiers in Immunology, Vol. 13, Article 974188
    Citations: 7
    🔬 This paper investigates the antitumor effects of an IL-2 ‘no-alpha’ mutein and its influence on the balance between CD8+ T cells and Tregs, contributing to cancer immunotherapy advancements.

Borhane Annabi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Dr. Borhane Annabi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Professor at Université du Québec à Montréal, Canada

Dr. Borhane Annabi is a distinguished professor in Biochemistry at Université du Québec à Montréal (UQAM) and a leader in cancer research. With a solid academic foundation, he has significantly contributed to the fields of metabolic regulation and tumor biology. His passion for scientific inquiry is reflected in his extensive research work and commitment to mentoring emerging scientists. Dr. Annabi is known for his collaborative spirit and dedication to improving public health through innovative research. He actively engages in various scientific communities and committees, promoting ethical practices in research and enhancing institutional governance. His work has far-reaching implications in understanding metabolic disorders and cancer prevention. 🌟🔬

Professional profile

Education📚

Dr. Borhane Annabi obtained his B.Sc. in Biochemistry from Université de Montréal in 1990, laying the groundwork for a successful academic career. He pursued his M.Sc. in Biochemistry at the same institution, focusing on metabolic endocrinology, culminating in a thesis on hepatic glycogen metabolism in genetically obese Zucker rats. His dedication to research led him to earn a Ph.D. in Biochemistry in 1997, again from Université de Montréal. His doctoral research centered on the liver microsomal glucose-6-phosphatase system, exploring its transport and hydrolytic functions. This strong educational foundation, enriched by rigorous research training, has equipped Dr. Annabi with the expertise to tackle complex biological problems. His academic journey reflects his commitment to advancing the field of biochemistry and contributing to critical health-related issues. 🎓📚

Professional Experience🏛️

Dr. Annabi’s professional journey is marked by significant contributions to biochemistry and cancer research. Since 2010, he has served as a Full Professor at UQAM, where he leads research efforts in metabolic and molecular oncology. He previously held the role of Associate Professor at the Université de Montréal in the Pharmacology and Physiology Department. His administrative experience includes directing the Institutional Research Chair in Cancer Prevention and Treatment at UQAM and previously leading the Canada Research Chair in Molecular and Metabolic Oncology. Dr. Annabi has also been involved in various internal committees, enhancing research governance and ethical standards within the institution. His experience encompasses a blend of teaching, research leadership, and community service, emphasizing his commitment to academia and the scientific community. His roles reflect a dedication to fostering research excellence and mentoring the next generation of scientists. 💼🔍

Research Interest🌐

Dr. Annabi’s research interests lie primarily in metabolic regulation, cancer biology, and the molecular mechanisms underlying tumor development and progression. His work focuses on understanding how metabolic pathways influence cancer cell behavior, particularly in relation to tumor angiogenesis and growth. He is deeply engaged in studying the molecular genetics of Glycogen Storage Disease and its implications for metabolic disorders. Additionally, Dr. Annabi explores the role of membrane proteins in cellular signaling and their potential as therapeutic targets in cancer treatment. His interdisciplinary approach integrates biochemistry, genetics, and oncology, fostering innovative solutions for pressing health challenges. Dr. Annabi actively collaborates with various research institutions, promoting knowledge exchange and driving impactful research initiatives. His commitment to advancing the understanding of metabolic and cancer-related processes continues to shape the future of biochemistry and health sciences. 🔬🧬

Awards and Honors🏆

Dr. Borhane Annabi’s research excellence has garnered several accolades throughout his career. His contributions to biochemistry and cancer research have been recognized through various awards and honors, reflecting his impact on the scientific community. Notably, he has received funding from prestigious institutions, enabling significant advancements in cancer prevention and treatment research. As a founding member of key research initiatives, Dr. Annabi has played a pivotal role in shaping research directions in oncology. His involvement in professional organizations and advisory roles demonstrates recognition by peers in his field. Furthermore, his dedication to ethical research practices and mentoring young scientists has earned him respect and admiration within the academic community. These honors serve as a testament to his influence and commitment to advancing knowledge in biochemistry and health sciences. 🏆🎖️

Publications top noted📜
  • Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation
    🧬 B. Annabi, Y.T. Lee, S. Turcotte, E. Naud, R.R. Desrosiers, M. Champagne, … (2003)
    📄 Stem Cells, 21(3), 337-347 — Citations: 427
  • Mesenchymal stromal cell–derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction
    🩸 M. Rafei, J. Hsieh, S. Fortier, M.Y. Li, S. Yuan, E. Birman, K. Forner, M.N. Boivin, … (2008)
    📄 Blood, 112(13), 4991-4998 — Citations: 294
  • Green tea polyphenol (−)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells
    🍵 B. Annabi, M.P. Lachambre, N. Bousquet-Gagnon, M. Pagé, D. Gingras, … (2002)
    📄 Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1542(1-3), 209-220 — Citations: 222
  • Green tea catechins as novel antitumor and antiangiogenic compounds
    🍃 M. Demeule, J. Michaud-Levesque, B. Annabi, D. Gingras, D. Boivin, S. Lamy, … (2002)
    📄 Current Medicinal Chemistry-Anti-Cancer Agents, 2(4), 441-463 — Citations: 211
  • The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression
    🌱 A. Belkaid, J.C. Currie, J. Desgagnés, B. Annabi (2006)
    📄 Cancer Cell International, 6, 1-12 — Citations: 201
  • Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains
    🔬 B. Annabi, M.P. Lachambre, N. Bousquet-Gagnon, M. Pagé, … (2001)
    📄 Biochemical Journal, 353(3), 547-553 — Citations: 195
  • Transmembrane topology of glucose-6-phosphatase
    🔄 C.J. Pan, K.J. Lei, B. Annabi, W. Hemrika, J.Y. Chou (1998)
    📄 Journal of Biological Chemistry, 273(11), 6144-6148 — Citations: 192
  • Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion
    💊 B. Annabi, M.P. Lachambre, K. Plouffe, R. Moumdjian, R. Béliveau (2009)
    📄 Pharmacological Research, 60(5), 438-445 — Citations: 190
  • Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms
    🔍 B. Annabi, D. Shédid, P. Ghosn, R.L. Kenigsberg, R.R. Desrosiers, … (2002)
    📄 Journal of Vascular Surgery, 35(3), 539-546 — Citations: 188
  • Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP)
    ⚙️ D. Gingras, N. Bousquet-Gagnon, S. Langlois, M.P. Lachambre, B. Annabi, … (2001)
    📄 FEBS Letters, 507(2), 231-236 — Citations: 154
  • The gene for glycogen-storage disease type 1b maps to chromosome 11q23
    🧬 B. Annabi, B.C. Mansfield, H. Hiraiwa, K.J. Lei, T. Ubagai, … (1998)
    📄 The American Journal of Human Genetics, 62(2), 400-405 — Citations: 148
  • Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors
    🌿 B. Annabi, E. Naud, Y.T. Lee, N. Eliopoulos, J. Galipeau (2004)
    📄 Journal of Cellular Biochemistry, 91(6), 1146-1158 — Citations: 122
  • ANG4043, a novel brain-penetrant peptide–mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice
    💥 A. Regina, M. Demeule, S. Tripathy, S. Lord-Dufour, J.C. Currie, M. Iddir, … (2015)
    📄 Molecular Cancer Therapeutics, 14(1), 129-140 — Citations: 120
  • Caveolin and cavin family members: dual roles in cancer
    ⚖️ R. Gupta, C. Toufaily, B. Annabi (2014)
    📄 Biochimie, 107, 188-202 — Citations: 111

Angelo Montana | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof. Angelo Montana | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Research at University Politecnica della Marche, Ancona, Italy

Prof. Angelo Montana, MD, PhD, is a distinguished expert in forensic medicine and toxicology. He earned his PhD in Legal Medicine and Forensic Sciences from Sapienza University of Rome in 2022, following a specialization in Forensic Medicine from Palermo University in 2017, and a medical degree from University of Catania in 2011, all with top honors. Currently, he serves as an Adjunct Professor at Politecnica delle Marche University in Ancona, Italy, where he teaches forensic medicine and toxicology. His professional experience includes roles as a Visiting Professor at Riga Stradins University and a Visiting Researcher at the University of Malta. Prof. Montana’s research focuses on forensic toxicology, postmortem analysis, and environmental health, contributing significantly to the field. His notable achievements include receiving the Stefano Jourdan Award (2017) and the Mauro Barni Award (2019).

Professional profile

Education📚

Prof. Angelo Montana holds a PhD in Legal Medicine and Forensic Sciences from Sapienza University of Rome (2022). He completed his specialization in Forensic Medicine at Palermo University (2017) with top honors, following his medical degree with distinction from University of Catania (2011). His academic journey reflects a deep commitment to forensic science and medicine.

Professional Experience🏛️

Prof. Montana serves as an Adjunct Professor of Forensic Sciences and Toxicology at Politecnica delle Marche University in Ancona, Italy, where he has been teaching since October 2018. He also engages in teaching forensic medicine and toxicology at the PhD level. His previous roles include being a Visiting Professor at Riga Stradins University and a Visiting Researcher at the University of Malta. His experience encompasses both academic and practical aspects of forensic science.

Research Interest🌐

Prof. Montana’s research focuses on forensic toxicology, forensic medicine, and environmental health. His work includes investigating postmortem toxicology, the effects of toxins, and advanced forensic techniques. His research contributes significantly to understanding and advancing forensic sciences, with particular attention to toxicological analysis and its implications.

Awards and Honors🏆

Prof. Montana has been recognized with several prestigious awards, including the Stefano Jourdan Award (2017) and the Mauro Barni Award (2019), highlighting his outstanding contributions to forensic medicine. These accolades underscore his impact and recognition in the field, both nationally and internationally.

Achievements🏅
  • Educational Excellence
    • PhD in Legal Medicine and Forensic Sciences, Sapienza University of Rome (2022) 🎓
    • Specialization in Forensic Medicine, Palermo University (2017) with cum laude honors 🎓
    • Degree in Medicine and Surgery, University of Catania (2011) with cum laude honors 🎓
  • Professional Experience
    • Adjunct Professor of Forensic Sciences and Toxicology at Politecnica delle Marche University, Ancona (since October 2018) 💼
    • Visiting Professor at Riga Stradins University, Latvia (2019) 🌍
    • Visiting Researcher at the University of Malta (2017) 🌍
  • Research Interests
    • Forensic toxicology and medicine 🔬
    • Postmortem toxicology and environmental health studies 🔬
  • Awards and Honors
    • Stefano Jourdan Award, COMLAS/Italy (2017) 🏆
    • Mauro Barni Award, ROMA/Italy (2019) 🏆
  • Scientific Contributions
    • Co-organizer of the 60th TIAFT Meeting (2023) 🗓️
    • Active member of editorial boards for journals such as European Review for Medical and Pharmacological Sciences and Journal of Pharmaceutical and Biomedical Analysis 📚
  • International Presentations
    • Poster presentations at annual TIAFT meetings (2013-2019) 🌍
    • Oral presentation at workshops on contemporary pathology and forensic medicine (2019) 🗣️
Publications top noted📜
  • Sudden Intrauterine Unexplained Death (SIUD) and Oxidative Stress: Placental Immunohistochemical Markers
    📝 Montana, A., Alfieri, L., Marino, R., Buffelli, F., Neri, M.
    Cells, 2024, 13(16), 1347
    📈 0 Citations
  • Forensic Perspectives on Postmortem CIED Interrogation: A Systematic Review and Meta-Analysis
    📝 Fede, M.S., Compagnucci, P., Montana, A., Giorgetti, R., Busardò, F.P.
    Forensic Science International, 2024, 359, 112001
    📈 0 Citations
  • The Main Causes of Orthopedics and Traumatology Litigation in Italy: State of the Art and Review of the Literature
    📝 Basile, G., Calori, G.M., Bianco Prevot, L., Leigheb, M., Montana, A.
    Minerva Orthopedics, 2024, 75(2), pp. 153–162
    📈 0 Citations
  • Macroscopic and Microscopic Cerebral Findings in Drug and Alcohol Abusers: The Point of View of the Forensic Pathologist
    📝 Montana, A., Alfieri, L., Neri, M., Tossetta, G., Busardò, F.P.
    Biomedicines, 2024, 12(3), 681
    📈 0 Citations
  • Application of Aquaporins as Markers in Forensic Pathology: A Systematic Review of the Literature
    📝 Alfieri, L., Montana, A., Frisoni, P., D’Errico, S., Neri, M.
    International Journal of Molecular Sciences, 2024, 25(5), 2664
    📈 1 Citation
  • Diagnostic Methods in Forensic Pathology: Autoptic Findings and Immunohistochemical Study in Cases of Sudden Death Due to a Colloid Cyst of the Third Ventricle
    📝 Montana, A., Busardò, F.P., Tossetta, G., Basile, G., Bambagiotti, G.
    Diagnostics, 2024, 14(1), 100
    📈 0 Citations
  • Molecular Insights of New Psychoactive Substances (NPS) 2.0
    📝 Di Trana, A., Montana, A., Lo Faro, A.F., Busardò, F.P., Pichini, S.
    International Journal of Molecular Sciences, 2023, 24(24), 17492
    📈 0 Citations
  • The Physiological and Pathological Cause in the Definition of the Compensation for Traumatic Knee Pathology: Forensic Medicine Perspective
    📝 Basile, G., Fozzato, S., Bianco Prevot, L., Montana, A., Leigheb, M.
    Gazzetta Medica Italiana Archivio per le Scienze Mediche, 2023, 182(11), pp. 841–849
    📈 0 Citations
  • End-of-Life in the Operational Functioning of Public Healthcare: Ethical and Legal Issues
    📝 Basile, G., De Nina, A., Montana, A., Napoletano, G., Marinelli, E.
    Acta Biomedica, 2023, 94(2), e2023110
    📈 2 Citations
  • Synthetic Cathinones and Neurotoxicity Risks: A Systematic Review
    📝 Daziani, G., Lo Faro, A.F., Montana, V., Giorgetti, R., Montana, A.
    International Journal of Molecular Sciences, 2023, 24(7), 6230
    📈 17 Citations

Dingan Zhou | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof. Dingan Zhou | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Assistant research fellow at Clinical Research Center at the Affiliated Hospital of Guizhou Medical University, China

Prof. Ding’an Zhou is an esteemed researcher and associated research fellow at the Clinical Research Center of the Affiliated Hospital of Guizhou Medical University. He is also a postgraduate mentor at the School of Clinical Laboratory Science, Guizhou Medical University. 🏥🎓

Professional profile

Education📚

Prof. Zhou earned his PhD in Biochemistry and Molecular Biology from Fudan University in Shanghai, China, in December 2012. His doctoral research focused on the causative genes and mechanisms of genetic diseases such as dyschromatosis universalis hereditarian (DUH) and autosomal dominant congenital cataract. 🎓🔬

Professional Experience🏛️

Following his PhD, Prof. Zhou worked as an Assistant Research Fellow at the First Affiliated Hospital of Chongqing Medical University starting in March 2013. His work there delved into the mechanisms underlying DUH phenotypes and the role of SASH1 as a tumor suppressor in breast cancer. In March 2017, he returned to Guiyang, his hometown, to join the Affiliated Hospital of Guizhou Medical University. 🏥🔍

Research Interest🌐

Prof. Zhou’s research interests are broad and include the identification of causative genes and mechanisms in rare genetic diseases, such as DUH, multiple endocrine neoplasia type 1 (MEN1), Retinitis Pigmentosa, 11 β-hydroxylase deficiency (11β-OHD), and Schmid type metaphyseal chondrodysplasia (SMCD). He is also focused on the post-translational modifications (phosphorylation and ubiquitylation) of key molecules in breast cancer. 🧬🔬

Awards and Honors🏆

Prof. Zhou has been honored with the Thousand Talents Innovation Award under the Hundred Million Talent Introduction Plan of Guizhou Province. This prestigious award recognizes his significant contributions and innovations in his field. 🏆🌟

Achievements🏅
  • PhD in Biochemistry and Molecular Biology: Awarded by Fudan University, focusing on genetic diseases such as dyschromatosis universalis hereditarian (DUH) and congenital cataract. 🎓🔬
  • Research on DUH and Breast Cancer: Investigated mechanisms of DUH phenotypes and the role of SASH1 as a tumor suppressor in breast cancer during his tenure at the First Affiliated Hospital of Chongqing Medical University. 🔍🧬
  • Thousand Talents Innovation Award: Received the prestigious award under the Hundred Million Talent Introduction Plan of Guizhou Province, recognizing his impactful research and contributions. 🏆🌟
  • Broad Research Scope: Conducted extensive research on genetic diseases, including MEN1, Retinitis Pigmentosa, 11 β-hydroxylase deficiency (11β-OHD), and Schmid type metaphyseal chondrodysplasia (SMCD). 🧬🔍
  • Post-Translational Modification Studies: Explored phosphorylation and ubiquitylation modifications of key molecules in breast cancer, contributing valuable insights to cancer research. 🧬🔬
Publications top noted📜
  • “A novel genomic rearrangement on chr19q13.42 leads to PRPF31-associated retinitis pigmentosa”
    Authors: Lu, Q., Yang, J., Xiong, Y., Zhang, M., Zhou, D.
    Journal: Clinical and Experimental Ophthalmology, 2024, 52(5), pp. 595–598
    Citations: 1 📖🔬
  • “Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer”
    Authors: Yang, P., Li, Y., Hou, J., Zeng, X., Zhou, D.
    Journal: Journal of Biological Chemistry, 2024, 300(6), 107309
    Citations: 0 📖🚫
  • “The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis”
    Authors: Li, Y., Zhou, Y., Zhao, C., Zhou, D., Jin, F.
    Journal: Oral Oncology, 2024, 152, 106798
    Citations: 2 📖🌟
  • “Dickkopf-1 is an immune infiltration-related prognostic biomarker of head and neck squamous cell carcinoma”
    Authors: Zhao, C., Liu, L., He, Q., Zhou, D., Jin, F.
    Journal: Aging, 2024, 16(4), pp. 3837–3855
    Citations: 1 📖🔬
  • “Unequal crossing over between CYP11B2 and CYP11B1 causes 11 β -hydroxylase deficiency in a consanguineous family”
    Authors: Xiong, Y., Zeng, Z., Liang, T., Zhang, M., Zhou, D.
    Journal: Journal of Steroid Biochemistry and Molecular Biology, 2023, 233, 106375
    Citations: 5 📖🌟
  • “Retyping and molecular pathology diagnosis of dyschromatosis universalis hereditaria”
    Authors: Zhou, D., Yang, P., Chen, H.
    Journal: Experimental Dermatology, 2023, 32(9), pp. 1334–1343
    Citations: 1 📖🔬
  • “The PER3 rs772027021 SNP induces pigmentation phenotypes of dyschromatosis universalis hereditaria”
    Authors: Chen, H., Yang, P., Yang, D., Xing, Q., Zhou, D.
    Journal: Journal of Molecular Medicine, 2023, 101(3), pp. 279–294
    Citations: 3 📖🔬
  • “The biological clock gene BMAL1 inhibits the proliferation, migration and invasion of radiation-resistant nasopharyngeal carcinoma cell line 5-8FR by regulating PI3K/Akt/MMP-2/9 signaling pathway”
    Authors: Li, Y., Zhao, C., Liu, L., Zhou, J., Jin, F.
    Journal: Chinese Journal of Radiation Oncology, 2022, 31(11), pp. 1039–1045
    Citations: 0 📖🚫
  • “Association between platelets and in-hospital mortality in critically ill patients with tumours: a retrospective cohort study”
    Authors: Zhao, C., Qin, Z., Tang, Y., Zhou, D., Jin, F.
    Journal: BMJ Open, 2022, 12(4), e053691
    Citations: 1 📖🔬